Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
85.65 EUR | +2.94% | +0.97% | -3.50% |
05-01 | European Equities Traded in the US as American Depositary Receipts Trend Modestly Lower in Wednesday Trading | MT |
04-25 | Sector Update: Health Care Stocks Drop in Afternoon Trading | MT |
Sales 2024 * | 2.79B 2.99B 239B | Sales 2025 * | 2.72B 2.92B 233B | Capitalization | 20.78B 22.3B 1,777B |
---|---|---|---|---|---|
Net income 2024 * | -562M -603M -48.07B | Net income 2025 * | -529M -568M -45.25B | EV / Sales 2024 * | 2.42 x |
Net cash position 2024 * | 14.03B 15.07B 1,200B | Net cash position 2025 * | 13.43B 14.41B 1,148B | EV / Sales 2025 * | 2.7 x |
P/E ratio 2024 * |
-36.8
x | P/E ratio 2025 * |
-36.5
x | Employees | 6,133 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 86.48% |
Latest transcript on BioNTech SE
1 day | +2.94% | ||
Current month | -3.50% | ||
Current year | -3.50% |
Managers | Title | Age | Since |
---|---|---|---|
Ugur Sahin
CEO | Chief Executive Officer | 58 | 01/06/08 |
Özlem Türeci
FOU | Founder | 57 | 01/06/08 |
Jens Holstein
DFI | Director of Finance/CFO | 60 | 30/06/21 |
Members of the board | Title | Age | Since |
---|---|---|---|
Rudolf Staudigl
BRD | Director/Board Member | 69 | 31/12/21 |
Director/Board Member | 67 | 01/06/08 | |
Helmut Jeggle
CHM | Chairman | 53 | 01/06/08 |
Date | Price | Change | Volume |
---|---|---|---|
02/05/24 | 85.65 | +2.94% | 930 |
30/04/24 | 83.2 | +0.79% | 128 |
29/04/24 | 82.55 | +0.49% | 1,562 |
26/04/24 | 82.15 | +1.61% | 2,807 |
25/04/24 | 80.85 | -1.52% | 278 |
Delayed Quote Börse Stuttgart, May 02, 2024 at 05:49 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-1.65% | 104B | |
+6.75% | 97.47B | |
+5.71% | 22.25B | |
-9.70% | 18.2B | |
-39.98% | 17.02B | |
-10.17% | 16.36B | |
+6.12% | 14.39B | |
+35.47% | 12.37B | |
+307.09% | 8.43B |
- Stock Market
- Equities
- BNTX Stock
- 22UA Stock